Gastroenterology
Volume 123, Issue 2 , Pages 414-424 , August 2002

Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production

  • Yoshio Yamaoka

      Affiliations

    • Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
    • ,
  • Shogo Kikuchi

      Affiliations

    • Department of Public Health, Aichi Medical University School of Medicine, Aichi, Japan
    • ,
  • Hala M.T. El–Zimaity

      Affiliations

    • Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
    • ,
  • Oscar Gutierrez

      Affiliations

    • Department of Medicine, Universidad Nacional de Colombia, Bogota, Colombia
    • ,
  • Michael S. Osato

      Affiliations

    • Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas
    • ,
  • David Y. Graham

      Affiliations

    • Department of Medicine, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas

Received 21 February 2002 ,Accepted 11 April 2002.

References 

  1. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996;93:14648–14653
  2. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111–2115
  3. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40:297–301
  4. van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, Boer WD, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115:58–66
  5. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem. 1995;270:17771–17777
  6. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997;112:92–99
  7. Peek RM, Thompson SA, Donahue JP, Tham TK, Atherton JC, Blaser MJ, et al. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Phys. 1998;110:531–544
  8. Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, et al. Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001;158:647–654
  9. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A. 1999;96:12778–12783
  10. Ilver D, Arnquist A, Ögren J, Frick IM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279:373–377
  11. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A. 2000;97:7533–7538
  12. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol. 1994;25:221–226
  13. El-Zimaity HMT, Ota H, Scott S, Killen DE, Graham DY. A new stain for Helicobacter pylori suitable for the autostainer. Arch Pathol Lab Med. 1998;122:732–736
  14. El-Zimaity HMT, Ramchatesingh J, Ali Saeed M, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2000;54:679–683
  15. El-Zimaity HMT, Graham DY, Al-Assi MT, Malaty H, Karttunen TJ, Graham DP, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol. 1996;27:35–41
  16. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter. 1998;4:241–253
  17. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999;37:2274–2279
  18. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388:539–547
  19. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328–1333
  20. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci U S A. 1999;96:14559–14564
  21. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A. 2000;97:1263–1268
  22. Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastricepithelial cells. J Exp Med. 2000;191:593–602
  23. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by typeIV secretion. Science. 2000;287:1497–1500
  24. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, et al. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol. 2001;8:181–186
  25. Mukhopadhyay AK, Kersulyte D, Jeong JY, Datta S, Ito Y, Chowdhury A, et al. Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India. J Bacteriol. 2000;182:3219–3227
  26. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene-positive Helicobacter pylori strains. Gut. 1997;41:442–451
  27. Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut. 1998;42:609–617
  28. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between clinical presentation, Helicobacter pylori density, interleukin-1β and -8 production and cagA status. Gut. 1999;45:804–811
  29. Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, et al. Helicobacter pylori genotypes are associated with clinical outcome in Portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001;36:128–135
  30. Zheng PY, Hua J, Yeoh KG, Ho B. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000;47:18–22
  31. Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, et al. Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease. Am J Gastroenterol. 2001;96:1008–1013
  32. Kidd M, Peek RM, Lastovica AJ, Israel DA, Kummer AF, Louw JA. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut. 2001;49:629–635
  33. Prinz C, Schöniger M, Rad R, Becker I, Keiditsch E, Wagenpfeil S, et al. Key Importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res. 2001;61:1903–1909
  34. Azuma T, Ito S, Sato F, Yamazaki Y, Miyaji H, Ito Y, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer. 1998;82:1013–1018
  35. El-Omar EM, Carrington M, Chow W-H, McColl KEL, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404:398–402 (correction published in Nature 2001;412:99)
  36. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredol C, et al. Interleukin 1β and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology. 2001;121:823–829
  37. Forman D. Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infection?. Aliment Pharmacol Ther. 1998;12(suppl 1):3–7
  38. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model. Gastroenterology. 1997;113:1983–1991
  39. Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol. 2000;35(suppl 12):90–97

☆ Address requests for reprints to: Yoshio Yamaoka, M.D., Ph.D.,Veterans Affairs Medical Center (111D), 2002 Holcombe Blvd., Houston, Texas 77030. e-mail: yyamaoka@bcm.tmc.edu; fax: (713) 790-1040.

☆☆ Supported in part by the Merit Review Program of the Department of Veterans Affairs, by NIH grants DK53659 and DK56338, and by the generous support of Hilda Schwartz.

PII: S0016-5085(02)00119-1

doi: 10.1053/gast.2002.34781

Gastroenterology
Volume 123, Issue 2 , Pages 414-424 , August 2002

Article Tools

* Image Usage & Resolution